The reproducibility of data obtained from the recently developed anterior eye segment analysis system (EAS-1000) was evaluated. 40 normal eyes and 62 cataractous eyes were examined at Kanazawa Medical University Hospital or Yayoi Hospital. The radius of the corneal curvature, the corneal thickness, anterior chamber depth, whole lens thickness, anterior chamber angle and the scattering light intensity were all observed on a slit section of the lens, and the intrapupillary area of the cataractous shadow was measured from a retroillumination image. The measurements were made twice at an interval of 14.2 days. There were no significant differences between the data of the 1 st and 2nd examination in either place.
Yasuo Sakamoto, Department of Ophthalmology, Kanazawa Medical University, Daigaku 1-1, Uchinada, Ishikawa 920-02 (Japan)
Published online: December 10, 2009
Number of Print Pages : 11
Ophthalmic Research (Journal for Research in Experimental and Clinical Ophthalmology)
Vol. 24, No. Suppl. 1, Year 1992 (Cover Date: 1992)
Journal Editor: Pleyer U. (Berlin)
ISSN: 0030-3747 (Print), eISSN: 1423-0259 (Online)
For additional information: http://www.karger.com/ORE
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.